Investing.com - Novo Nordisk (CSE:NOVOb) ADR reported on Wednesday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Novo Nordisk ADR announced earnings per share of kr4.01 on revenue of kr32.14B. Analysts polled by Investing.com anticipated EPS of kr0.6039 on revenue of kr5.19B.
Novo Nordisk ADR shares are up 1.6% from the beginning of the year and are trading at kr70.97 , down-from-52-week-high.They are outperforming the EUR/USD which is down 0% from the start of the year.
Novo Nordisk ADR follows other major Healthcare sector earnings this month
Novo Nordisk ADR's report follows an earnings beat by J&J on January 26, who reported EPS of kr1.86 on revenue of kr22.48B, compared to forecasts EPS of kr1.82 on revenue of kr21.66B.
Abbott Labs had beat expectations on January 27 with fourth quarter EPS of kr1.45 on revenue of kr10.7B, compared to forecast for EPS of kr1.35 on revenue of kr9.94B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar